sales imminent article .profitable in 2011 ?, page-35

gsk and Dr Reddys do have connections. I can't imagine gsk ruining their Arixtra market by offering the generic at a really low price. I wouldn't be surprised if there's a bit of a gentlemans agreement here, a bit like Qantas and Virgin Blue used to offer the same fares.

Remember too that Bioshares once suggest acl might make Arixtra for GSK. Maybe a deal will be done where they supply all three. A $10m upfront payment and we can start HyACTing!

The other senario is a takeover offer, which can't be far off if it's going to happen.